2017 - Latest Guidelines for Combination Products Registration - 2017

Overview:
During this introductory session, delegates will gain a complete guide to the status and impact of the latest guidelines for combination products.
Why should you Attend:
This webinar will examine the regulatory requirements for drug device combinations in the case of a drug and a device and for integral products.This webinar will cover the basic requirements of how to stay compliant.
Areas Covered in the Session:
Interfacing,Development,Quality,Regulatory
Managing third parties and document control
Vigilance and adverse event reporting
Who Will Benefit:
Regulatory Affairs
Medical Officers
Speaker Profile:
Salma Michor , PhD, MSc, MBA, CMgr, RAC is founder and CEO of Michor Consulting Schweiz GmbH, serving such clients as Johnson & Johnson, Novartis, Shire, Pfizer and Colgate Palmolive. Previously, Michor worked for Chiesi-Torrex, Wyeth Whitehall Export Croma Pharma GmbH.
Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support-AT-compliance4All.com